CD Genomics enjoys a high reputation for sequencing, microarray analysis, library construction and genotyping, providing reliable services to pharmaceutical and biotechnology companies as well as academia and government agencies. Based on rich experience in targeted sequencing, CD Genomics has developed a specialized platform for targeted sequencing of disease-related genes to accelerate research on disease pathogenesis, disease identification, biomarker discovery, targeted drug development, etc. CD Genomics offers predesigend NGS panels, which include a designed library of targeted sequencing, as well as a custom panel that allows customers to select genes of interest to design their own sequencing panels.
To be the most trusted partner with pharmaceutical and biotechnology companies as well as academia and government agencies for Disease Targeted Sequencing.
Submit a high quality, high accuracy report on gene variants to our customer.
We provide custom panels for mutation detection. The genes we can detect are not limited to the reference genes we have listed. As long as you have the genes of interest, you are welcome to contact us. We will give you a satisfactory answer after discussion.MORE PROJECT